Pharmacokinetics of Levodopa and 3-O-Methyldopa in Parkinsonian Patients Treated with Levodopa and Ropinirole and in Patients with Motor Complications

• Príomhchruthaitheoirí: Urszula Adamiak-Giera (Údar), Wojciech Jawień (Údar), Anna Pierzchlińska (Údar), Monika Białecka (Údar), Jan Dariusz Kobierski (Údar), Tomasz Janus (Údar), Barbara Gawrońska-Szklarz (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: MDPI AG, 2021-09-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Parkinson's disease (PD) is a progressive, neurodegenerative disorder primarily affecting dopaminergic neuronal systems, with impaired motor function as a consequence. The most effective treatment for PD remains the administration of oral levodopa (LD). Long-term LD treatment is frequently asso...